0001078782-15-000002.txt : 20150102 0001078782-15-000002.hdr.sgml : 20150101 20150102123527 ACCESSION NUMBER: 0001078782-15-000002 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20141222 ITEM INFORMATION: Other Events FILED AS OF DATE: 20150102 DATE AS OF CHANGE: 20150102 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VOLITIONRX LTD CENTRAL INDEX KEY: 0000093314 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 911949078 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-30402 FILM NUMBER: 15500788 BUSINESS ADDRESS: STREET 1: 150 ORCHARD ROAD CITY: ORCHARD PLAZA 08-02 STATE: U0 ZIP: 238841 BUSINESS PHONE: 000-000-0000 MAIL ADDRESS: STREET 1: 150 ORCHARD ROAD CITY: ORCHARD PLAZA 08-02 STATE: U0 ZIP: 238841 FORMER COMPANY: FORMER CONFORMED NAME: STANDARD CAPITAL CORP DATE OF NAME CHANGE: 19990812 8-K 1 f8k123014_8k.htm FORM 8-K CURRENT REPORT FORM 8-K Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 8-K


CURRENT REPORT


PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934


Date of Report (Date of earliest event reported): January 2, 2015 (December 22, 2014)


VolitionRX Limited

(Exact name of registrant as specified in its charter)


Delaware

 

000-30402

 

91-1949078

(State or other jurisdiction of Incorporation)

 

(Commission File Number)

 

(IRS Employer Identification Number)


1 Scotts Road

#24-05 Shaw Centre

Singapore 228208

(Address of principal executive offices)

 

+1 (646) 650-1351

(Registrant’s Telephone Number)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


      .Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)


      .Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)


      .Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))


      .Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))




VOLITIONRX LIMITED

Form 8-K

Current Report


ITEM 8.01 OTHER EVENTS


Change in Corporate Transfer Agent


On December 22, 2014, VolitionRX Limited (the “Corporation”) dismissed Holladay Stock Transfer as its transfer agent and registrar of the securities of the Corporation effective on December 30, 2014. As of December 24, 2014, the Corporation has appointed VStock Transfer, LLC, a California limited liability company, to act as the transfer agent and registrar of the Corporation’s securities.






SIGNATURE


Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.



VOLITIONRX LIMITED


Date: January 2, 2015

By:

/s/ Cameron Reynolds

Cameron Reynolds

Chief Executive Officer & President



2